Patent details

EP2254571 Title: COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE

Basic Information

Publication number:
EP2254571
PCT Application Number:
PCT/US/2009/036608
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097215222
PCT Publication Number:
WO/2009/117277
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE
French Title of Invention:
COMBINAISONS DE CONJUGUÉS ANTICORPS ANTI-HER2-MÉDICAMENT ET D AGENTS CHIMIOTHÉRAPIQUES, ET PROCÉDÉS D UTILISATION
German Title of Invention:
KOMBINATION AUS EINEM ANTI-HER2 ANTIKÖRPER-WIRKSTOFF-KONJUGAT UND CHEMOTHERAPEUTIKA SOWIE VERWENDUNGSVERFAHREN
SPC Number:

Dates

Filing date:
10/03/2009
Grant date:
01/07/2015
EP Publication Date:
01/07/2015
PCT Publication Date:
24/09/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/12/2010
EP B1 Publication Date:
01/07/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/03/2016
Expiration date:
10/03/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/03/2009
 
 

Name:
Genentech Inc.
Address:
1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
PHILLIPS Gail, Lewis
Address:
United States (US)

2

Name:
BERRY Leanne
Address:
United States (US)

3

Name:
SLIWKOWSKI Mark, X.
Address:
United States (US)

Priority

Priority Number:
37410 P
Priority Date:
18/03/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/337;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages